Colchicine in Percutaneous Coronary Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 714 participants.

Also called NCT02594111

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 714 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02594111
Other papers using this trial's data
  • Neutrophil Activation and Adhesiveness in Coronary Artery Disease: Results From the COLCHICINE-PCI Biomarker Substudy Journal of the American Heart Association, 2024-10 DOI, PubMed 39344637, PMC11681481 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02594111. Randomized; quadruple masking; primary purpose treatment. Start 2013-05-30 (actual); primary completion 2019-08-30 (actual). Results posted on 2020-07-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine in Percutaneous Coronary Intervention
Acronym
Colchicine-PCI
Condition
Acute Coronary Syndrome
Intervention (Drug)
Colchicine vs Placebo
Lead sponsor
VA Office of Research and Development (class: US federal agency)
Collaborator
NYU Langone Health (class: other)

Record details

Record id
cardio:ct-nct02594111
Content hash
17cbe39cdb9a23d275890a56db79da011024dbe420f6522569473ea94e2c7f3f